WuXi AppTec Co., Ltd. (HKG:2359)
99.15
-0.95 (-0.95%)
Aug 8, 2025, 4:08 PM HKT
WuXi AppTec Revenue
WuXi AppTec had revenue of 11.14B CNY in the quarter ending June 30, 2025, with 20.37% growth. This brings the company's revenue in the last twelve months to 41.48B, up 11.95% year-over-year. In the year 2024, WuXi AppTec had annual revenue of 37.92B, down -1.97%.
Revenue (ttm)
41.48B CNY
Revenue Growth
+11.95%
P/S Ratio
6.36
Revenue / Employee
1.05M CNY
Employees
39,414
Market Cap
289.24B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37.92B | -760.22M | -1.97% |
Dec 31, 2023 | 38.68B | -676.78M | -1.72% |
Dec 31, 2022 | 39.35B | 16.45B | 71.84% |
Dec 31, 2021 | 22.90B | 6.37B | 38.50% |
Dec 31, 2020 | 16.54B | 3.66B | 28.46% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 35.81B |
Hansoh Pharmaceutical Group Company | 13.05B |
Innovent Biologics | 10.03B |
JD Health International | 61.89B |
Akeso | 2.26B |
Sino Biopharmaceutical | 30.72B |
WuXi Biologics | 19.87B |
CSPC Pharmaceutical Group | 28.99B |